ReviewGut microbes2025
REG/Reg family proteins: mediating gut microbiota homeostasis and implications in digestive diseases.
Review in Gut microbes, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Systematic evaluation of PASEF acquisition strategies in complex metaproteomes.Nature communications · 2026Article
- Intestinal epithelial SETD2 maintains gut microbial homeostasis to attenuate colitis.Clinical and translational medicine · 2026Article
- Cold Exposure Alleviates Colitis via Parallel Integration of Colonic Mucosal Regeneration and Ileal Antimicrobial Defense.Biomedicines · 2026Article
- Natural and Synthetic Peptides as Alternatives to Antibiotics in Intestinal Infections-A Review.Antibiotics (Basel, Switzerland) · 2026Review
- The bidirectional effects and mechanisms of the oral and gut microbiomes: a narrative review.Frontiers in immunology · 2026Review
- Gut microbiota-epigenetic interactions in systemic aging: mechanistic drivers for endocrine and reproductive network remodeling and therapeutic modulation.Frontiers in aging · 2026Review
- REG3A: A Potential Fecal Biomarker for Ulcerative Colitis.Mediators of inflammation · 2026Article
- Gut microbiota-host adaptive immune interactions in type 2 diabetes mellitus: mechanisms, disease progression, and microbiota-based therapeutic strategies.Frontiers in microbiology · 2026Review
Corrections and comments
- Erratum issuedCorrection.2025
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The regenerating (REG/Reg) family, a subset of the C-type lectin fold superfamily, is characterized by "C-type lectin-like" domains. Beyond promoting proliferation and differentiation of hepatic, pancreatic, gastric, and intestinal cells, its members have multifunctional secretory activities, especially as antimicrobial peptides (AMPs), a key link between their structural features and roles in gastrointestinal physiology/pathology. These molecules mediate the initiation and progression of various gastrointestinal inflammatory and inflammation-associated diseases. As AMPs, they connect gut microbiome and host immunity by regulating microbiota homeostasis, intestinal mucosal barrier, metabolism, and energy balance; notably, REG3/4 play dual roles in digestive tract diseases. This review proposes the REG Protein Functional Equilibrium Model. REG proteins act as context-dependent "molecular rheostats" switching between protective and pathogenic roles based on microenvironmental cues. The functional equilibrium model provides a new paradigm for developing precision therapeutics that target the microenvironment rather than single molecules, offering critical theoretical foundations for resolving the functional paradox of REG family in inflammation and cancer and advancing its clinical translation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.